Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with polyangiitis
dc.contributor.author | Besada, Emilio | |
dc.contributor.author | Koldingsnes, Wenche | |
dc.contributor.author | Nossent, Johannes C | |
dc.date.accessioned | 2015-03-02T08:53:39Z | |
dc.date.available | 2015-05-15T05:50:05Z | |
dc.date.issued | 2014-05-15 | |
dc.identifier.citation | Rheumatology (2014) 53 (10): 1818-1824. | en_US |
dc.identifier.cristinID | FRIDAID 1132995 | |
dc.identifier.doi | 10.1093/rheumatology/keu194 | |
dc.identifier.issn | 1462-0324 | |
dc.identifier.uri | https://hdl.handle.net/10037/7256 | |
dc.identifier.urn | URN:NBN:no-uit_munin_6842 | |
dc.language.iso | eng | en_US |
dc.publisher | Oxford University Press | en_US |
dc.rights.accessRights | openAccess | |
dc.subject | 759 | en_US |
dc.title | Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with polyangiitis | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |